HACD2 has been increasingly reported in the literature as a tumor marker,[16, 26, 27] and HACD2 deficiency can cause angiogenic arrest and further lead to embryonic lethality.[17] However, its biological function and mechanism of action in tumors are still unclear. This evidence concerns the gene HACD2 and neoplasm.